Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03069495 · ClinicalTrials.gov registry record
Role of Circulating Innate Lymphoid Cells in Allergic Disorders
A clinical trial, sponsored by University of Nebraska.
- Terminated
- Registry status
- 18
- Enrollment target
NCT03069495 is a clinical trial that was terminated before completion, run by University of Nebraska. The registered enrollment target is 18 participants.
The verdict
NCT03069495 was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- 18 participants
- Enrollment target
Study Summary
This study evaluates blood type 2 innate lymphoid cells in participants with mild to moderate asthma and participants with chronic urticaria as compared to healthy adult participants.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2017-08-21 |
| Est. Completion | 2020-02-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03069495
The ClinicalTrials.gov registry entry for NCT03069495 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03069495 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03069495 about?
NCT03069495 is a clinical study titled "Role of Circulating Innate Lymphoid Cells in Allergic Disorders". This study evaluates blood type 2 innate lymphoid cells in participants with mild to moderate asthma and participants with chronic urticaria as compared to healthy adult participants.
What is the current status of trial NCT03069495?
This trial is currently terminated. The enrollment target is 18 participants. The study started on 2017-08-21. Estimated completion is 2020-02-24.
Who is sponsoring clinical trial NCT03069495?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.